In summary, the current data demonstrate that Enza-induced increase of PCAT6 expression promotes prostate cancer neuroendocrine differentiation by regulating miR-326/Hnrnpa2b1 axis. The gene discussed is HNRNPA2B1; the disease is prostate carcinoma.